+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Porcine Vaccines - Global Strategic Business Report - Product Thumbnail Image

Porcine Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 376 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Thumbnail Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • November 2024
  • 265 Pages
  • Global
From
Cancer Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cancer Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 403 Pages
  • Global
From
From
Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 262 Pages
  • Global
From
Human Microbiome - Global Strategic Business Report - Product Thumbnail Image

Human Microbiome - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
Antivenoms - Global Strategic Business Report - Product Thumbnail Image

Antivenoms - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
Microbiome Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Microbiome Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 181 Pages
  • Global
From
Therapeutic Vaccines - Global Strategic Business Report - Product Thumbnail Image

Therapeutic Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
Plasma Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
From
COVID-19 Vaccines - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 762 Pages
  • Global
From
From
From
Spine Biologics - Global Strategic Business Report - Product Thumbnail Image

Spine Biologics - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Meningococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Meningococcal Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Biologics Safety Testing - Global Strategic Business Report - Product Thumbnail Image

Biologics Safety Testing - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more